Parallel Advisors »

4d Molecular Therapeutics In shares owned by Parallel Advisors

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.1k 33 31.85
2023-12-31 $668 33 20.27
2023-09-30 $0 0 0.00

More positions owned by Parallel Advisors

Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Ishares S&p 500 Index Etf (IVV)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Corcept Therapeutics Stock (CORT)
Ishares Msci Usa Quality Factor Etf Etf (QUAL)
Microsoft Stock (MSFT)
Amazon.com Stock (AMZN)
Guggenheim Etf Trust S&p 500 Equal Weight Etf (RSP)
Ishares Aggregate Bond Etf Etf (AGG)
Ishares Core Msci Eafe Etf Etf (IEFA)
Vanguard Large Cap Etf (VV)
Cvb Finl Corp Stock (CVBF)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Google Stock (GOOGL)

View all positions for Parallel Advisors

Top funds holding 4d Molecular Therapeutics In

Viking Global Investors
RA Capital Management
BVF
VR Adviser
Henderson Group
Vanguard Group
Arrowpoint Asset Management
Casdin Capital
Goldman Sachs Group
Dimensional Fund Advisors
Deutsche Bank Aktiengesellschaft
Eagle Health Investments
Assenagon Asset Management
Jpmorgan Chase & Co
Point72 Asset Management

View all funds holding 4d Molecular Therapeutics In